Evidence map›Paper›PMID 38864976›Full record

SynthesisJournal of epidemiology and global health2024

Prevalence of Human Toxoplasmosis in Spain Throughout the Three Last Decades (1993-2023): A Systematic Review and Meta-analysis.

Mariola Miguel-Vicedo, Paula Cabello, M Carmen Ortega-Navas, David González-Barrio, Isabel Fuentes

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of epidemiology and global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. HumanMicroorganisms · 2025
    Article
  4. Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mariola Miguel-Vicedo *Toxoplasmosis and Protozoosis Unit, Parasitology Reference and Research Laboratory, Spanish National Centre for Microbiology, Health Institute Carlos III, Majadahonda, Madrid, Spain.ORCID http://orcid.org/0009-0008-3689-3468
Paula Cabello *International University of Valencia-VIU, 46002, Valencia, Spain.ORCID http://orcid.org/0000-0002-3639-5951
M Carmen Ortega-NavasDepartment of Educational Theory and Social Pedagogy, National University of Distance Education (UNED) Madrid, Madrid, Spain.ORCID http://orcid.org/0000-0001-5651-1262
David González-BarrioToxoplasmosis and Protozoosis Unit, Parasitology Reference and Research Laboratory, Spanish National Centre for Microbiology, Health Institute Carlos III, Majadahonda, Madrid, Spain. dgonzalezbarrio@gmail.com.ORCID http://orcid.org/0000-0001-5083-8854
Isabel FuentesToxoplasmosis and Protozoosis Unit, Parasitology Reference and Research Laboratory, Spanish National Centre for Microbiology, Health Institute Carlos III, Majadahonda, Madrid, Spain. ifuentes@isciii.es.ORCID http://orcid.org/0000-0003-3605-6252

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Humans are infected by Toxoplasma gondii worldwide and its consequences may seriously affect an immune deprived population such as HIV and transplanted patients or pregnant women and foetuses. A deep knowledge of toxoplasmosis seroprevalence in Spain is needed in order to better shape health policies and educational programs. We present the results of the first systematic review and meta-analysis on the human prevalence for this disease in Spain. Databases (PubMed, Web of Science, SCOPUS and Teseo) were searched for relevant studies that were published between January 1993 and December 2023 and all population-based cross-sectional and longitudinal studies reporting the human seroprevalence in Spain were revised. Within the population analysed, our targeted groups were immunocompetent population, pregnant women and immunocompromised patients. Among 572 studies and 35 doctoral theses retrieved, 15 studies and three doctoral theses were included in the meta-analysis. A random effects model was used for the meta-analyses due to the high heterogeneity found between studies (I

Indexed as

ToxoplasmosisFemaleHumansPregnancyPrevalenceSeroepidemiologic StudiesSpainToxoplasmaCerebral toxoplasmosisHIV patientHumanPregnant womanPrevalenceSeroprevalenceSpainToxoplasma gondiiToxoplasmosis

Identifiers

PMID38864976
PMCPMC11444046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.